课题基金 / 基金详情

National HIV Behavioral Surveillance System - NHBS Core

National HIV Behavioral Surveillance System - NHBS Core
国家艾滋病毒行为监测系统 - NHBS 核心
批准号:
8120149
负责人:
Ralph Wilmoth
金额:
$47.9万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2015-12-31

项目摘要

项目成果

Ralph Wilmoth的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Abstract The principal objective of the National HIV Behavioral Surveillance System (NHBS) is to monitor risk behaviors and access to prevention services among three populations at highest risk for HIV infection in the United States: men who have sex with men (MSM), injection-drug users (IDU), and heterosexuals at increased risk for HIV (HET). The NHBS strategy involves rotating 12-month cycles of surveillance activities in these three populations. The Denver Metropolitan Statistical Area (MSA) has been involved with NHBS since its inception in 2003. The Colorado Department of Public Health and Environment (CDPHE), as the state health department, will serve as the grantee for this award with the primary responsibility for meeting stated objectives contracted to Denver Public Health (DPH), the local city health department. In order to achieve the objectives outlined in the funding announcement, we propose the following specific aims: 1) To assess and monitor risk behaviors and access to prevention services among three populations at highest risk for HIV infection in the Denver MSA: MSM, IDU, and HET, 2) To evaluate the seroprevalence of HIV, HCV, and HBV infection in the MSM, IDU, and HET populations at risk for HIV infection in the Denver MSA, 3) To conduct new HIV testing technologies during the MSM cycle, and 4) To analyze, disseminate, and utilize NHBS data to realize the greatest public health impact in the Denver MSA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STD PREVENTION PROGRAM ARKANSAS DEPT OF HEALTH
HIV SURVEILLANCE
HIV SURVEILLANCE
HIV SURVEILLANCE
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究